Navigating the tumor microenvironment: mesenchymal stem cell-mediated delivery of anticancer agents
- 6 May 2024
- journal article
- review article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 32 (6) , 624-634
Abstract
Scientific knowledge of cancer has advanced greatly throughout the years, with most recent studies findings includes many hallmarks that capture disease's multifaceted character. One of the novel approach utilized for the delivery of anti-cancer agents includes mesenchymal stem cell mediated drug delivery. Mesenchymal stem cells (MSCs) are non-hematopoietic progenitor cells that may be extracted from bone marrow, tooth pulp, adipose tissue and placenta/umbilical cord blood dealing with adult stem cells. MSCs are mostly involved in regeneration of tissue, they have also been shown to preferentially migrate to location of several types of tumor in-vivo. Usage of MSCs ought to improve both effectiveness and safety of anti-cancer drugs by enhancing delivery efficiency of anti-cancer therapies to tumor site. Numerous researches has demonstrated that various drugs, when delivered via mesenchymal stem cell mediated delivery can elicit anti-tumor effect of cells in cancers of breast cells and thyroid cells. MSCs have minimal immunogenicity because to lack of co-stimulatory molecule expression, which means there is no requirement for immunosuppression after allogenic transplantation. This current review elaborates recent advancements of mesenchyma stem cell mediated drug delivery of anti-cancer agents along with its mechanism and previously reported studies of drugs manufactured via this drug delivery system.Keywords
This publication has 108 references indexed in Scilit:
- Nanoghosts: Harnessing Mesenchymal Stem Cell Membrane for Construction of Drug Delivery Platforms Via Optimized BiomimeticsSmall, 2023
- Advances in Mesenchymal Stem Cell Therapy for Immune and Inflammatory Diseases: Use of Cell-Free Products and Human pluripotent Stem Cell-Derived Mesenchymal Stem CellsStem Cells Translational Medicine, 2021
- Cancer statistics for the year 2020: An overviewInternational Journal of Cancer, 2021
- The Role of Organic Synthesis in the Emergence and Development of Antibody–Drug Conjugates as Targeted Cancer TherapiesAngewandte Chemie International Edition, 2019
- Mesenchymal Stem Cell-Derived Extracellular Vesicles as Therapeutics and as a Drug Delivery PlatformStem Cells Translational Medicine, 2019
- Concise Review: Mesenchymal Stem Cells: From Roots to BoostStem Cells, 2019
- Human Genomic Safe Harbors and the Suicide Gene-Based Safeguard System for iPSC-Based Cell TherapyStem Cells Translational Medicine, 2019
- Gene therapy clinical trials worldwide to 2017: An updateThe Journal of Gene Medicine, 2018
- Paracrine Mechanisms of Mesenchymal Stem Cells in Tissue Repair2016
- The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell‐mediated VEGF production and tumour angiogenesis via PI3K/AKT signallingThe Journal of Pathology, 2011